| Drug Name | (Revlimid®(Lenalidomide |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
patient guide
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
Safety information about risk of Risk of teratogenicity |
| patient guide |
|
| Dear Healthcare provider letter DHPC |
|
| other |
I-secure program |